Cited by 1,924Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyAbdominal Surgery and Complications

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Open access

Russell, James A., Walley, Keith R., Singer, Joel, Gordon, Anthony C., Hébert, Paul C., Cooper, D. James, Holmes, Cheryl L., Mehta, Sangeeta, Granton, John T., Storms, Michelle M., Cook, Deborah J., Presneill, Jeffrey J., Ayers, Dieter·2008·New England Journal of Medicine

DOI 10.1056/nejmoa067373

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. METHODS: In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 microg of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 microg per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. RESULTS: A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). CONCLUSIONS: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869 [controlled-trials.com].).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa067373

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310

Flagged first, then by citations

Show all 36 references

Research works printed but not linked: 2

Argenziano M, 1997, Circulation, 96, II
Chen JM, 1999, Circulation, 100, II

Sorted by citations

Items 901–999 of 999

The Specific Organism: Not Bacterial Gram Type: Drives the Inflammatory Response in Septic Shock
Linder, A., Fjell, C. D., Inghammar, M., Hsu, J. L., Walley, K. R., Boyd, J. H., & Russell, J. A. (2019) · Journal of Innate Immunity · doi:10.1159/000500418 · Cited by 8
Self-citation
Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock
Allen, J. M., & Gilbert, B. W. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.09.014 · Cited by 8
Perioperative Management of Patients with Sepsis and Septic Shock, Part I
Bughrara, N. F., Cha, S., Safa, R., & Pustavoitau, A. (2020) · Anesthesiology Clinics · doi:10.1016/j.anclin.2019.10.013 · Cited by 8
Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis
Durst, M. M., Eitzen, E. A., & Benken, S. T. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020980727 · Cited by 8
Dose equivalence between metaraminol and norepinephrine in critical care
Sardaneh, A. A., Goradia, S., Narayan, S. W., Penm, J. H.-D., McLachlan, A. J., & Patanwala, A. E. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14969 · Cited by 8
Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study
Kloter, M., Gregoriano, C., Haag, E., Kutz, A., Müeller, B., & Schüetz, P. (2021) · Endocrine Connections · doi:10.1530/ec-21-0211 · Cited by 8
Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial
Schulz, J., Bauer, I., Herminghaus, A., Picker, O., Truse, R., & Vollmer, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257034 · Cited by 8
Putting midodrine on the MAP: An approach to liberation from intravenous vasopressors in vasodilatory shock
Smith, S. E., Peters, N. A., Floris, L. M., Patterson, J. M., & Hawkins, W. A. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac069 · Cited by 8
Advances in Sepsis Care
Jackson, K. E., & Semler, M. W. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.05.003 · Cited by 11
Inotropes and Vasopressors Use in Critical Care and Perioperative Medicine: Evidence-Based Approach (Review)
Belletti, A., Azzolini, M. L., Baldetti, L., Landoni, G., Franco, A., & Zangrillo, A. (2022) · General Reanimatology · doi:10.15360/1813-9779-2022-5-60-77 · Cited by 8
Inotrope and Vasopressor Therapy of Septic Shock
Hollenberg, S. M. (2011) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2010.12.008 · Cited by 8
Year in review 2009: Critical Care - shock
Stahl, W., Bracht, H., Radermacher, P., & Thomas, J. (2010) · Critical Care · doi:10.1186/cc9261 · Cited by 8
Arginine vasopressin, via activation of post-junctional V1 receptors, induces contractile effects in mouse distal colon
Mastropaolo, M., Zizzo, M. G., Auteri, M., Mulè, F., & Serio, R. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.10.005 · Cited by 8
Risk factors for mortality in septic patients who received etomidate
Rech, M. A., Bennett, S., Chaney, W., & Sterk, E. J. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.07.062 · Cited by 8
β2-Agonists and Acute Respiratory Distress Syndrome
Budinger, G. R. S., & Mutlu, G. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0170ed · Cited by 8
Conceitos atuais sobre suporte hemodinâmico e terapia em choque séptico
Rocha, L. L., Pessoa, C. M. S., Corrêa, T. D., Pereira, A. J., de Assunção, M. S. C., & Silva, E. (2015) · Brazilian Journal of Anesthesiology · doi:10.1016/j.bjan.2015.07.003 · Cited by 8
Vasopressor use in 41 critically ill cats (2007-2016).
Licht, N., Rozanski, E. A., & Rush, J. E. (2018) · PubMed Central · Cited by 8
Advances in Vasodilatory Shock: A Concise Review
Thakur, S. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23266 · Cited by 8
Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial
Harhay, M. O., Gasparini, A., Walkey, A. J., Weissman, G. E., Crowther, M. J., Ratcliffe, S. J., & Russell, J. A. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000104 · Cited by 8
Self-citation
Modern Vasopressor Therapy of Septic Shock (Review)
Kochkin, А. А., Yavorovskiy, A. G., Бондоевич, Б. Л., & Likhvantsev, V. V. (2020) · General Reanimatology · doi:10.15360/1813-9779-2020-2-77-93 · Cited by 9
Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus
Carsetti, A., Bignami, E., Cortegiani, A., Donadello, K., Donati, A., Foti, G., Grasselli, G., ROMAGNOLI, S., Antonelli, M. M., Blasio, E. D., et al. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14866-1 · Cited by 8
Does the Implementation of a Quality Improvement Care Bundle Reduce the Incidence of Acute Kidney Injury in Patients Undergoing Emergency Laparotomy?
Doyle, J. F., Sarnowski, A., Saadat, F., Samuels, T. L., Huddart, S., Quiney, N., Dickinson, M., McCormick, B., deBrunner, R., Preece, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081265 · Cited by 8
Update in Critical Care 2008
Fowler, R., Adhikari, N. K. J., Scales, D. C., Lee, W. L., & Rubenfeld, G. D. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0207up · Cited by 8
The cellular mechanisms underlying the inhibitory effects of isoflurane and sevoflurane on arginine vasopressin-induced vasoconstriction
Shimogai, M., Ogawa, K., Tokinaga, Y., Yamazaki, A., & Hatano, Y. (2010) · Journal of Anesthesia · doi:10.1007/s00540-010-1033-z · Cited by 8
Glucocorticoids in sepsis: dissecting facts from fiction
Sprung, C. L., Annane, D., Singer, M., Moreno, R. P., Keh, D., & the CORTICUS Study Group (2011) · Critical Care · doi:10.1186/cc10428 · Cited by 8
What Definition Should We Use for Sepsis and Septic Shock?*
Sprung, C. L., & Trahtemberg, U. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002544 · Cited by 8
Is It Time to Reconsider the Concept of “Salvage Therapy” in Refractory Shock?*
Wieruszewski, P. M., Sevransky, J., & Roberts, R. J. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006003 · Cited by 8
Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial
Endo, A., Yamakawa, K., Tagami, T., Umemura, Y., Takahashi, K., Nagasawa, H., Araki, Y., Kojima, M., Sera, T., Yagi, M., et al. (2022) · Trials · doi:10.1186/s13063-022-06732-9 · Cited by 8
Evaluation of Dose Requirements Using Weight-Based versus Non-Weight-Based Dosing of Norepinephrine to Achieve a Goal Mean Arterial Pressure in Patients with Septic Shock
Selby, A. R., Khan, N. S., Dadashian, T., & Hall, R. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041344 · Cited by 7
Emerging concepts in the care of patients with cirrhosis and septic shock
Jiménez, J. V., García–Tsao, G., & Saffo, S. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i4.497 · Cited by 9
Hypoperfusion context as a predictor of 28-d all-cause mortality in septic shock patients: A comparative observational study
Kataria, S., Singh, O., Juneja, D., Goel, A., Bhide, M., & Yadav, D. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i16.3765 · Cited by 7
Limb Necrosis in the Setting of Vasopressor Use
Derry, K. H., Rocks, M. C., Izard, P., Nicholas, R. S., Sommer, P. M., & Hacquebord, J. H. (2024) · American Journal of Critical Care · doi:10.4037/ajcc2024171 · Cited by 7
ADJUNCTIVE VASOPRESSORS AND SHORT-TERM MORTALITY IN ADULTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS
Bauer, S. R., Wieruszewski, P. M., Bissell, B. D., Dugar, S. P., Sacha, G. L., Sato, R., Siuba, M., Schleicher, M. C., Vachharajani, V., Falck-Ytter, Y. T., et al. (2025) · Shock · doi:10.1097/shk.0000000000002558 · Cited by 8
Early multimodal vasopressor strategy in septic shock (TRICYCLE)—Study protocol for a randomized controlled clinical trial
Kalamar, Ž., Gorenjak, M., Landoni, G., & Markota, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331304 · Cited by 8
Non-Invasive Hemodynamic Monitoring in Critically Ill Patients: A Guide for Emergency Physicians
Beltrame, M., Bellan, M., Patrucco, F., & Gavelli, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14197002 · Cited by 12
Early vasopressin plus norepinephrine versus delayed or no vasopressin in septic shock: A systematic review and meta-analysis
Mamede, I., Arêa, L., Carvalhal, G., Filho, R. B. S., Lenzi, M., & dos Santos, M. C. F. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.10.003 · Cited by 8
Timing of Vasopressin Initiation in Patients with Septic Shock: An Updated Systematic Review and Meta-analysis with Trial Sequential Analysis
Bhattacharjee, A., Datta, P. K., Kumar, V., Ravikumar, R. H., Sathe, P., & Kundu, R. (2025) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25054 · Cited by 9
Mastering the practical application of vasopressin at the bedside in septic shock
Léone, M., Khanna, A. K., & Wieruszewski, P. M. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08204-5 · Cited by 7
Analysis of prognostic risk factors in critically ill elderly patients with sepsis-associated acute kidney injury
Zeng, J., Zhang, Y. X., Zhang, M., Feng, K., Guo, W., Ge, Y., Chen, W., Li, J., Cheng, A., & Bai, J. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04630-1 · Cited by 7
Evaluation of Response to High-Dose Intravenous Vitamin K Administration
Chapman, A. R., Yerke, J. R., Lumpkin, M., Rudoni, M. A., Militello, M. A., Wang, L., & Bass, S. N. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231154246 · Cited by 7
Comparison of Early Versus Late Adjunctive Vasopressin and Corticosteroids in Patients With Septic Shock
Alshehri, A. M., Kovacevic, M. P., Dube, K. M., Lupi, K. E., & DeGrado, J. R. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231191131 · Cited by 7
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock
Mergoum, A. M., Rhone, A., Larson, N. J., Dries, D. J., Blondeau, B., & Rogers, F. B. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241246230 · Cited by 8
Recent trends in septic shock management: a narrative review of current evidence and recommendations
Nofal, M. A., Shitawi, J., Altarawneh, H. B., Alrosan, S., Alqaisi, Y., Al-Harazneh, A.-M., Alamaren, A. M., & Abu‐Jeyyab, M. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002048 · Cited by 10
Have we found the prevention for intensive care unit-acquired paresis?
Ali, N. A. (2010) · Critical Care · doi:10.1186/cc9005 · Cited by 7
Terlipressin or Europressin?
Léone, M. (2009) · Critical Care · doi:10.1186/cc8035 · Cited by 7
A Human Vascular Model Based on Microdialysis for the Assessment of the Vasoconstrictive Dose–Response Effects of Norepinephrine and Vasopressin in Skin
Folkesson, T., Samuelsson, A., Tesselaar, E., Dahlström, B. E., & Sjöberg, F. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00170.x · Cited by 7
Does Switching Norepinephrine to Phenylephrine in Septic Shock Complicated by Atrial Fibrillation With Rapid Ventricular Response Improve Time to Rate Control?
Haiduc, M., Radparvar, S., Aitken, S. L., & Altshuler, J. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066619896292 · Cited by 7
Increased risk of catheter‐related infection in critically ill patients given catecholamine inotropes during continuous renal replacement therapy
Liu, X., Ye, H., Zheng, X., Zheng, Z., Chen, W., & Yu, X. (2021) · Hemodialysis International · doi:10.1111/hdi.12968 · Cited by 7
Advantages of score-based delirium detection compared to a clinical delirium assessment—a retrospective, monocentric cohort study
Jäckel, M., Aicher, N., Bemtgen, X., Rilinger, J., Zotzmann, V., Biever, P. M., Supady, A., Stachon, P., Duerschmied, D., Wengenmayer, T., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259841 · Cited by 7
Vasogenic shock physiology
Mentzelopoulos, S. D., & Gkizioti, S. (2011) · Open Access Emergency Medicine · doi:10.2147/oaem.s10388 · Cited by 7
Angiotensin-II
Asfar, P., Chawla, L. S., Lerolle, N., & Radermacher, P. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000436 · Cited by 7
Fluid choices impact outcome in septic shock
Douglas, J. J., & Walley, K. R. (2014) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000116 · Cited by 7
Self-citation
Vasopressin in Septic Shock
Gordon, A. C. (2011) · Journal of the Intensive Care Society · doi:10.1177/175114371101200105 · Cited by 8
Self-citation
Effects of Vasopressin in Septic Shock
Ruggiero, M. S. (2008) · AACN Advanced Critical Care · doi:10.1097/01.aacn.0000330379.34142.5b · Cited by 7
Diretrizes para tratamento da sepse grave/choque séptico: ressuscitação hemodinâmica
Westphal, G. A., Silva, E., Salomão, R., Bernardo, W. M., & Machado, F. R. (2011) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2011000100004 · Cited by 7
The impact of endocrine supplementation on adverse events in septic shock
Bissell, B. D., Erdman, M. J., Smotherman, C. R., Kraemer, D. F., & Ferreira, J. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.08.025 · Cited by 7
Cardiovascular physiology
Chambers, D. J., Huang, C. L.-H., & Matthews, G. D. K. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139226394.028 · Cited by 7
Predictors of Vasopressin Responsiveness in Critically Ill Adults
Allen, B., Kram, B., Kram, S. J., Schultheis, J. M., Wolf, S., Gilstrap, D. L., & Shapiro, M. A. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017729480 · Cited by 7
Use of vasopressin in the treatment of refractory septic shock
Kny, K. T., Ferreira, M. A. P., & Pizzol, T. D. S. D. (2018) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20180060 · Cited by 7
Year in review 2008: Critical Care - metabolism
Preiser, J. (2009) · Critical Care · doi:10.1186/cc8024 · Cited by 7
Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis
Song, J., Lee, J. H., Park, H. K., Suh, G. Y., & Jeon, K. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e8 · Cited by 7
Establishing the Therapeutic Index of Fluid Resuscitation in the Septic Patient: A Narrative Review and Meta‐Analysis
Reynolds, P., Wells, L., MacLaren, R., & Scoular, S. K. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2371 · Cited by 8
Major publications in the critical care pharmacotherapy literature: 2019
Smith, M. N., Basting, A. T., Costello, P. G., DePriest, A., Eriksson, E. A., Evans, H. L., Hertel, K. A., Holder, A. L., Kester, A. N., Kowalski, K., et al. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.018 · Cited by 7
Evaluation and treatment of the critically ill cirrhotic patient
Fernández, J., Aracil, C., Solà, E., Soriano, G., Cardona, M. C., Coll, S., Genescà, J., Hombrados, M., Morillas, R. M., Martín–Llahí, M., et al. (2016) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2016.10.004 · Cited by 7
Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study
Arishi, H., AlQahtani, S. Y., Tamim, H., Sadat, M., Alenezi, F. Z., Humaid, F. B., Wehaibi, W. A., & Arabi, Y. M. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154121 · Cited by 7
Vasoactive drugs and acute kidney injury
Bellomo, R., Wan, L., & May, C. N. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318187b8ac · Cited by 7
Clinical Practice Guidelines for Improving Outcomes in Sepsis
Ihle, B. U. (2008) · Heart Lung and Circulation · doi:10.1016/j.hlc.2008.08.005 · Cited by 7
Catecholamines and the Septic Heart
Radermacher, P., Huber-Lang, M. S., & Thiemermann, C. (2013) · Shock · doi:10.1097/shk.0b013e31828b247b · Cited by 7
Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy
Sterling, J. A. (2007) · Hospital Pharmacy · doi:10.1310/hpj4206-578 · Cited by 7
CRITICAL NOREPINEPHRINE DOSE TO PREDICT EARLY MORTALITY DURING CIRCULATORY SHOCK IN INTENSIVE CARE: A RETROSPECTIVE STUDY IN 3423 ICU PATIENTS OVER 4-YEAR PERIOD
Ceausu, D., Boulet, N., Roger, C., Alonso, S., Lefrant, J., Boisson, C., Mura, T., & Muller, L. (2024) · Shock · doi:10.1097/shk.0000000000002454 · Cited by 6
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery
Miles, T. J., Guinn, M. T., Suero, O. R., Rosengart, T. K., Moon, M. R., Coselli, J. S., Ghanta, R. K., & Chatterjee, S. (2025) · JTCVS Open · doi:10.1016/j.xjon.2025.04.014 · Cited by 6
Prevention and Management of Perioperative Acute Kidney Injury: A Narrative Review
Duplechin, M. O., Folds, G. T., Duplechin, D. P., Ahmadzadeh, S., Myers, S. H., Shekoohi, S., & Kaye, A. D. (2025) · Diseases · doi:10.3390/diseases13090295 · Cited by 10
Blood pressure response index trajectories identify distinct hemodynamic phenotypes and predict mortality in septic shock: a two-database retrospective cohort study
Shen, Y., Zhang, W. M., Lin, K., Zheng, P., Liu, X., Weng, J., & Ye, Y. (2026) · Critical Care · doi:10.1186/s13054-026-06059-w · Cited by 8
Hypotensive resuscitation in combination with arginine vasopressin may prolong the hypotensive resuscitation time in uncontrolled hemorrhagic shock rats
Yang, G., Hu, Y., Peng, X., Zhu, Y., Zang, J., Li, T., & Liu, L. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000564 · Cited by 6
Tissue Inhibitor of Metalloproteinases-2 Mediates Kidney Injury during Sepsis
Wen, X., Zhang, J., Wan, X., Frank, A. A., Qu, X., & Kellum, J. A. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000511165 · Cited by 6
Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review
Subba, H., Riker, R. R., Dunn, S., & Gagnon, D. J. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211053497 · Cited by 6
Evaluación y manejo de emergencias en el paciente con cirrosis
Velasco, J. A. V.-R., García-Jiménez, E. S., Aldana-Ledesma, J. M., Tapia-Calderón, D. K., Tornel-Avelar, A. I., Lazcano-Becerra, M., Chávez-Ramírez, R. M., Cano-Contreras, A. D., Remes-Troche, J. M., Colunga‐Lozano, L. E., et al. (2022) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2021.11.002 · Cited by 7
Updates in the Management of Perioperative Vasoplegic Syndrome
Brennan, K. M., Bhutiani, M., Kingeter, M. A., & McEvoy, M. D. (2022) · Advances in Anesthesia · doi:10.1016/j.aan.2022.07.010 · Cited by 7
V asopressin I nitiation as a S econd-Line Vaso P ressor in Early S eptic S hock (VISPSS)
Ragoonanan, D., Nickelsen, P. M., Tran, N., Allen, B., Emborski, R., Legare, A., Vilella, A. L., Hampson, L., Busey, K. V., Shomo, E., et al. (2023) · Journal of Intensive Care Medicine · doi:10.1177/08850666231201364 · Cited by 6
Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy
Ward, J. A., Yerke, J. R., Lumpkin, M., Kapoor, A., Lindenmeyer, C. C., & Bass, S. N. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i11.1226 · Cited by 6
The Association Between Vasopressin and Adverse Kidney Outcomes in Children and Young Adults Requiring Vasopressors on Continuous Renal Replacement Therapy
Hasson, D. C., Gist, K. M., Seo, J., Stenson, E. K., Kessel, A. D., Haga, T., LaFever, S., Santiago, M. J., Barhight, M. F., Selewski, D. T., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001156 · Cited by 6
Impact of the Sequence of Norepinephrine and Vasopressin Discontinuation in Patients Recovering From Septic Shock
Bredhold, B. E., Winters, S. D., Callison, J. C., Heidel, R. E., Allen, L. M., & Hamilton, L. A. (2018) · Hospital Pharmacy · doi:10.1177/0018578718817469 · Cited by 6
Vasoplegic syndrome in cardiac surgery: Definitions, pathophysiology, diagnostic approach and management
Vinasco, D. M. O., Schoonewolff, C. A. T., & Vinasco, A. C. O. (2019) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2018.12.010 · Cited by 6
Precision Medicine in Critical Illness: Sepsis and Acute Respiratory Distress Syndrome
Rogers, A. J., & Meyer, N. J. (2020) · Respiratory medicine · doi:10.1007/978-3-030-31507-8_18 · Cited by 7
Optimal VAsopressor TitraTION in patients 65 years and older (OVATION-65): protocol and statistical analysis plan for a randomised clinical trial
Masse, M.-H., Battista, M., Wilcox, M. E., Pinto, R. L., Marinoff, N., D’Aragon, F., St-Arnaud, C., Mayette, M., Leclair, M.-A., Quiroz-Martinez, H., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037947 · Cited by 6
Self-citation
Association of Methylene Blue Dosing With Hemodynamic Response for the Treatment of Vasoplegia
Hohlfelder, B., Douglas, A., Wang, L., Wanek, M. R., & Bauer, S. R. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.04.003 · Cited by 6
Endovascular Perfusion Augmentation for Critical Care Decreases Vasopressor Requirements while Maintaining Renal Perfusion
Patel, N. T. P., Gaffley, M. W. G., Leblanc, M. J. R., Lane, M. R., Kratky, L. E., Hoareau, G. L., Johnson, M. A., Jordan, J. E., Neff, L. P., & Williams, T. K. (2022) · Shock · doi:10.1097/shk.0000000000001917 · Cited by 6
Vasopressin-Induced Hyponatremia in Infants Following Cardiovascular Surgery
Bradford, C. V., Miller, J. L., Ranallo, C. D., Neely, S. B., & Johnson, P. N. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221103576 · Cited by 6
Selepressin in Septic Shock
Antonucci, E., Giovini, M., Agosta, S., Sakr, Y. L., & Léone, M. (2022) · Shock · doi:10.1097/shk.0000000000001932 · Cited by 6
Applicability of Vasopressor Trials in Adult Critical Care: A Prospective Multicentre Meta-Epidemiologic Cohort Study
Buchtele, N., Schwameis, M., Roth, D., Schwameis, F., Kraft, F., Ullrich, R., Mühlbacher, J., Laggner, R., Gamper, G., Semmler, G., et al. (2022) · Clinical Epidemiology · doi:10.2147/clep.s372340 · Cited by 6
On sepsis, troponin and vasopressin: the bitter truth
Gradwohl-Matis, I., & Dünser, M. W. (2013) · Critical Care · doi:10.1186/cc12772 · Cited by 6
Optimizing Drug Therapy in the Surgical Intensive Care Unit
Peppard, W. J., Peppard, S. R., & Somberg, L. B. (2012) · Surgical Clinics of North America · doi:10.1016/j.suc.2012.08.011 · Cited by 6
Translational research in sepsis - an ultimate challenge?
Kampmeier, T., Ertmer, C., & Rehberg, S. W. (2011) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-3-14 · Cited by 6
Design, conduct, and analysis of a multicenter, pharmacogenomic, biomarker study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated)
Annane, D., Mira, J., Ware, L., Gordon, A., Sevransky, J., Stüber, F., Heagerty, P., Wellman, H., Neira, M., Mancini, A. D. J., et al. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-15 · Cited by 5
Self-citation
Vasopressin vs noradrenaline: Have we found the perfect recipe to improve outcome in septic shock?
Chidambaram, S., Goh, E. L., Rey, V. G., & Khan, M. A. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.10.029 · Cited by 6
Analysis of Mortality in Patients Treated With Phenylephrine in Septic Shock
Patel, V. V., Sullivan, J., & Cavanaugh, J. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211000218 · Cited by 6
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients
Krishnan, K., Wassermann, T. B., Tednes, P., Bonderski, V. A., & Rech, M. A. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.11.003 · Cited by 7
Hypothalamic–pituitary–adrenal axis multiple and organ dysfunction syndrome in critical illness: A special focus on arginine-vasopressin and apelin
Gallo‐Payet, N., Roussy, J.-F., Chagnon, F., Roberge, C., & Lesur, O. (2008) · Journal of Organ Dysfunction · doi:10.1080/17471060802339711 · Cited by 6
Recently published papers: Sepsis – guidelines, treatment and novel approaches
Kalsi, N., & Forni, L. G. (2008) · Critical Care · doi:10.1186/cc6836 · Cited by 6

Authors: Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., Cook, D. J., Presneill, J. J., & Ayers, D.
Affiliations: St. Paul's Hospital (CA)
University of Ottawa (CA)
The Alfred Hospital (AU)
University of British Columbia (CA)
Mount Sinai Hospital (CA)
University of Toronto (CA)
McMaster University (CA)
The Royal Melbourne Hospital (AU)
ORCID: Russell, James A.
Walley, Keith R.
Singer, Joel
Gordon, Anthony C.
Hébert, Paul C.
Cooper, D. James
Holmes, Cheryl L.
Mehta, Sangeeta
Granton, John T.
Presneill, Jeffrey J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-02-28
Volume: 358
Issue: 9
Pages: 877-887
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa067373
OpenAlex: W2108153775
Cited by: 1,924
References: 36
Citations by year: 2026: 106 · 2025: 119 · 2024: 101 · 2023: 91 · 2022: 88 · 2021: 85 · 2020: 104 · 2019: 205 · 2018: 114 · 2017: 104 · 2016: 100 · 2015: 83 · 2014: 91 · 2013: 84 · 2012: 89
FWCI: 88.86
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
Keywords: septic shock, vasopressin, norepinephrine, vasopressor therapy, catecholamines, mortality, 28-day mortality, 90-day mortality, sepsis treatment, blood pressure support, adverse events, subgroup analysis
MeSH terms: Adult, Aged, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Norepinephrine, Severity of Illness Index, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Failure, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks